KPI THERAPEUTICS

KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors. The company believes that as an industry we can do better than develop just 20 to 30 new drugs per year. Our vision of KPI is to speed the progression of promising drug candidates through the critical translational stage of development and work with commercialization partners who have a strong commitment to improving access to important new medicines. It was founded in 2013 and headquartered in Seattle, Washington.
KPI THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Founded:
2013-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.kpitherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(206) 378-0400
Total Funding:
77.5 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Amazon AJAX Libraries API WordPress 6.0 GlobalSign Amazon California Region ClouDNS
Founder
Investors List
Keiretsu Capital
Keiretsu Capital investment in Venture Round - KPI Therapeutics
Keiretsu Capital
Keiretsu Capital investment in Series A - KPI Therapeutics
AngelMD
AngelMD investment in Series A - KPI Therapeutics
TSVC
TSVC investment in Series A - KPI Therapeutics
Keiretsu Forum
Keiretsu Forum investment in Series A - KPI Therapeutics
Official Site Inspections
http://www.kpitherapeutics.com
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney

More informations about "KPI Therapeutics"
KPI Therapeutics - Crunchbase Company Profile & Funding
KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors.See details»
Dr. Dale Bredesen - Chief Science Officer At Apollo Health
An internationally recognized expert in the mechanisms of neurodegenerative diseases, Dr. Dale Bredesenโs career has been guided by a simple idea: Alzheimerโs as we know it is not just โฆSee details»
KPI Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for KPI Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
KPI Therapeutics - Funding, Financials, Valuation & Investors
KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors.See details»
KPI Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for KPI Therapeutics, Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
KPI Therapeutics - Crunchbase
KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors.See details»
KPI Therapeutics, Inc. (KPI Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ โฆ
The inflammatory myositis market is anticipated to surge owing to improvements in diagnosis over the globe and thus the surge in treatment options. In addition, the expected launch of โฆSee details»
KPI Therapeutics - Products, Competitors, Financials, Employees ...
About KPI Therapeutics KPI Therapeutics, formerly Kineta, develops therapies backed by an alliance of development partners which drives focused, efficient drug development. The โฆSee details»
KPI Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials
Explore KPI Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Immune System Diseases, Technology Platform ...See details»
KPI Therapeutics - Company Profile - Tracxn
Nov 13, 2024 KPI Therapeutics - Small molecule drugs for autoimmune diseases and chronic pain indications. This company is not active anymore. Raised a total funding of $4.95M over 5 โฆSee details»
Dr. Bredesen's Study - Muses Labs - ApoE4.Info
Nov 4, 2015 Muses Labs is also working on refining their protocol recccommendations (such as expanding their dietary recommendations) and improving their protocol reports. They are still โฆSee details»
Biotech Consortium Launches KPI Therapeutics, Inc., a ... - Fierce โฆ
Jun 9, 2014 Paul Sylvester, CFO of MPI Research, Inc., a global contract research organization, and KPI Board member stated, "We have enjoyed our existing partnership with Kineta and โฆSee details»
Charles River Completes the Acquisition of MPI Research
Aug 22, 2018 MPI Research, a premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies โฆSee details»
An Interview with MPI Research - American Pharmaceutical Review
Jun 21, 2012 What sets MPI Research apart from competitors? MPI Research is the worldโs largest single-site preclinical contract research organization with more than one million square โฆSee details»
Therapeutics Initiative | Better prescribing. Better health.
Prescription drug therapy is a key element of medical care. The UBC Therapeutics Initiativeโs goal is for drug therapies to be used wisely in the best interests of patients, based on thorough and โฆSee details»
K36 Therapeutics - Crunchbase Company Profile & Funding
K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.See details»
MDI THERAPEUTICS, INC - VentureRadar
"MDI Therapeutics is a pharmaceutical company developing novel serpin-based therapies for the treatment of fibrosis and fibroproliferative disorders. The Company was founded on key โฆSee details»
MDI Therapeutics - Crunchbase Company Profile & Funding
MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.See details»
KOP THERAPEUTICS
KOP Therapeutics is a Canadian biotech company headquartered in Vancouver BC. KOPโs mission is to develop a non-toxic, affordable, targeted, immunotherapy-based mRNA drug for โฆSee details»
Pi Therapeutics - Crunchbase Company Profile & Funding
Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company โฆSee details»